Alloy vs MultiMedRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
MultiMedRx
Best for patients comfortable with a $100 refundable consultation fee who want the option of brand-name GLP-1s (Ozempic, Wegovy, Zepbound) plus broader cardiometabolic care (Metformin, HRT, TRT) under one platform with disclosed legal entity and physical office addressesSide-by-Side Comparison
| Feature | Alloy | MultiMedRx |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.8/10 |
| Starting Price | $80/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 3.4 ★ /5 |
| Features | 8 features | ✓9 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
MultiMedRx
Pros
- ✓Legal entity DISCLOSED verbatim in copyright footer: 'MMRX MultiMedRx™ LLC' — uncommon transparency vs peers who do not disclose entity name
- ✓Two physical addresses disclosed: Newport Beach, CA (Main Office, 1000 Quail St. #260) and Reno, NV (Telehealth Location, 401 Ryland St. #200-A)
- ✓LegitScript seal present
- ✓Prominently features BRAND-NAME GLP-1s (Ozempic, Wegovy, Zepbound) — uncommon vs the compounded-only segment that dominates the cluster
- ✓Multi-modality menu (Metformin, Testosterone, HRT) supports broader cardiometabolic care alongside GLP-1
- ✓$100 consultation fee is FULLY REFUNDABLE per the disclosed flow — risk-free intake
Cons
- ✗Mounjaro and Foundayo NOT mentioned in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
- ✗Steady-state monthly pricing for any GLP-1 (brand or compounded) NOT disclosed publicly — gated behind the consultation
- ✗$100 consultation fee is a friction point — most peer telehealth platforms bundle consultation into the medication price
- ✗Per-state availability NOT enumerated; only CA + NV offices disclosed (the telehealth model presumably extends further but the specific state list is not published)
- ✗Specific compounded GLP-1 product line NOT explicitly addressed — site positioning emphasizes brand-name (verify scope during intake if compounded is desired)
- ✗Partner pharmacy / dispensing pathway NOT publicly disclosed
- ✗State of incorporation NOT disclosed
- ✗Compounded pricing tier (if any) NOT disclosed
Our Verdict
Alloy edges out MultiMedRx with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. MultiMedRx remains a solid alternative, especially if you're looking for patients comfortable with a $100 refundable consultation fee who want the option of brand-name GLP-1s (Ozempic, Wegovy, Zepbound) plus broader cardiometabolic care (Metformin, HRT, TRT) under one platform with disclosed legal entity and physical office addresses.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.